| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000003623 |
| Receipt No. | R000004390 |
| Scientific Title | A phase II trial of endoscopic submucosal dissection (ESD) for superficial pharyngeal cancer |
| Date of disclosure of the study information | 2010/05/17 |
| Last modified on | 2020/05/25 (Ver. 7) |
| Basic information | ||
| Public title | A phase II trial of endoscopic submucosal dissection (ESD) for superficial pharyngeal cancer | |
| Acronym | A phase II trial of ESD for superficial pharyngeal cancer | |
| Scientific Title | A phase II trial of endoscopic submucosal dissection (ESD) for superficial pharyngeal cancer | |
| Scientific Title:Acronym | A phase II trial of ESD for superficial pharyngeal cancer | |
| Region |
|
|
| Condition | ||
| Condition | superficial pharyngeal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy and safety of ESD for superficial pharyngeal cancer. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Complete en block resection rate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Endoscopic submucosal dissection (ESD) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Superficial pharyngeal carcinoma confined to subepithelial lesion without lymphnode metastasis. | |||
| Key exclusion criteria | 1)Patients with hematologicalabnormality
2)Active synchronous or metachronous malignancy 3)Patients with severe organ failure 4)Others who were thought to be unsuitable by the investigator. 5)Patients who underwent radiation therapy. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Osaka Medical Center for Cancer and Cardiovascular Diseases | ||||||
| Division name | Gastrointestinal Oncology | ||||||
| Zip code | 537-8511 | ||||||
| Address | 1-3-3 Nakamichi, Higashinariku, Osaka 537-8511 Japan | ||||||
| TEL | 06-6972-1181 | ||||||
| hanaoka-no@mc.pref.osaka.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Osaka Medical Center for Cancer and Cardiovascular Diseases | ||||||
| Division name | Gastrointestinal Oncology | ||||||
| Zip code | 537-8511 | ||||||
| Address | nakamichi higashinari-ku 1-3-3 Osaka, Japan | ||||||
| TEL | 06-672-1181 | ||||||
| Homepage URL | |||||||
| hanaoka-no@mc.pref.osaka.jp | |||||||
| Sponsor | |
| Institute | Osaka Medical Center for Cancer and Cardiovascular Diseases |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka Medical Center for Cancer and Cardiovascular Diseases |
| Address | Nakamichi |
| Tel | 06-6972-1181 |
| mitui-ku@mc.pref.osaka.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004390 |